CaMaRa

Sidera

This company develops small molecule medicines for patients with metabolic, inflammatory and kidney diseases using human genetic research findings.

Marea Therapeutics

This biotechnology company develops medicines for cardiometabolic and cardioendocrine diseases using human genetic data for patients with unmet medical needs.

Airna

This company develops RNA editing therapeutics to treat patients with rare genetic and common cardiometabolic diseases.

Cardior

This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.

Rocket Pharma

This company develops gene therapies for patients with rare and devastating genetic cardiovascular and haematological diseases.

Adrestia

This company develops precision medicines for rare and common genetic diseases by using a molecular biology platform to identify and rescue cellular imbalances.

Empirico

The company develops genetic medicines and target discovery platforms for pharmaceutical partners and patients with common diseases.

SonoThera™

This company develops an ultrasound-guided non-viral platform to deliver genetic medicines for patients with chronic and rare diseases.